12:11 AM EDT, 10/20/2026 (MT Newswires) -- Ondine Biomedical (OBI.L) is aiming to raise 10 million pounds sterling from the sale of new common shares at 0.10 pound apiece. The London-listed life sciences company said Monday it will sell new shares through a placement and subscription. The final terms will be determined after an accelerated bookbuild process, with the results expected to be disclosed on Tuesday. Net proceeds from the share sale will support the commercial expansion and business development of the company, its regulatory activities in the US, production and operations, and general and administrative expenditures.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.